注射用透明质酸钠复合溶液治疗颈部横纹疗效观察  

Clinical Effect of an Injectable Sodium Hyaluronic Composite Solutionin the Treatment on Horizontal Neck Lines

作　　者：阮柱仁 梁虹[1] 戴杏[1] 陆玲[1] 董荔[1] 胡英姿[1] RUAN Zhu-ren;LIANG Hong;DAI Xing;LU Ling;DONG Li;HU Ying-zi(Department of Skin Medical Cosmetology,Renmin Hospital of Wuhan University,Wuhan 430060,Hubei,China)

机构地区：[1]武汉大学人民医院皮肤医疗美容科,湖北武汉430060

出　　处：《中国美容医学》2018年第1期43-46,共4页Chinese Journal of Aesthetic Medicine

摘　　要：目的:评估注射用透明质酸钠复合溶液(嗨体~?,北京爱美客技术发展股份有限公司)治疗颈部横纹的疗效及安全性。方法:给14例就医者使用透明质酸钠复合溶液注射填充治疗颈部横纹,共治疗3次,每次间隔4周。于治疗前、治疗后即刻、治疗3次后,最后一次治疗后3个月拍照并随访,记录不良反应。根据Allergan颈部横纹评分(Allergan Transverse Neck Lines Scale)、GAIS(global aesthetic improvement scale,GAIS)评价颈部横纹改善情况。结果:14例就医者的颈部横纹得到不同程度的改善,治疗3次后Allergan颈部横纹评分从治疗前的(2.50±0.85)分降至(1.71±0.83)分,研究者和就医者的GAIS评价结果显示治疗3次后的有效率高达86%,3个月后有效率为71%。治疗后出现少量针点出血及短暂的红斑、水肿、瘀青,均在短期内消退,无严重不良反应发生。结论:注射用透明质酸钠复合溶液(嗨体~?)治疗颈部横纹安全、有效。Objective To examine and access the clinical effect of Hearty?-an injectable sodium hyaluronic composite solution in the treatment forhorizontal neck lines.Methods A total of 14 participants with horizontal neck lines,were treated withsodium hyaluronic composite solution,all participants underwent up to three sessions of treatment at 4-week intervals.Allergan transverse neck lines scale,global aesthetic improvement scale(GAIS)and adverse events were evaluated by physician and participants independently at preoperative and immediately,after three sessions of treatment,and 3 months after the final treatment session.Results The score of Allergan transverse neck lines scale declined from(2.50±0.85)points to(1.71±0.83)points after three session of treatment,and the neck wrinkle appearance of 87%participants showed improvement according GAIS,70%found to be improved in follow-up 3 months after the final treatment session.Complications,such as erythema,swelling,bruising,were observed,but they were transient.Conclusion Hearty?injectable sodium hyaluronic composite solutionis a promising option for horizontal neck lines.

关 键 词：颈部横纹 透明质酸 皮肤填充剂 注射 

分 类 号：R452[医药卫生—治疗学]